reference/26469340

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26469340

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	773
issn	1948-5875
issueIdentifier	5
pageRange	768-773
publicationName	ACS Medicinal Chemistry Letters
startingPage	768
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2039a69b7060685032c9285b68ebe472 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a8374bec2b5d61065a63fc6af8621e46 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e28615b315f2c8d9c7c69098a7ffcd02 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b1052c14e8af051399dc405abdb4dde2
bibliographicCitation	Butera R, Ważyńska M, Magiera-Mularz K, Plewka J, Musielak B, Surmiak E, Sala D, Kitel R, de Bruyn M, Nijman HW, Elsinga PH, Holak TA, Dömling A. Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists. ACS Med. Chem. Lett. 2021 Apr 28;12(5):768–73. doi: 10.1021/acsmedchemlett.1c00033.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_146f92e9c218806e0274d80439c8f9e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4826-6380 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0307-0907 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc8169151ae5a31b35777861a7b8b19 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17d769cf33530d8838dbd68960ecca0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4103-4675 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28248b8025ccab27f94202bb34b45019 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1b7cbd2d807a6f37ff108b1502904bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1baf980df0d55c5a094096edb31b8899 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81798aa8471de70ca2fe053ef55fa722 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9923-8873 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9819-9131 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1626-7450 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_260f37e2b06ed53b1f7f86413d800290 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8978-9893 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1665-5920
date	2021-04-28^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1021/acsmedchemlett.1c00033 https://pubmed.ncbi.nlm.nih.gov/34055224 https://pubmed.ncbi.nlm.nih.gov/PMC8155249
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 https://portal.issn.org/resource/ISSN/1948-5875
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d36a5575512a3ece2898352e3aa40163 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78960 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7095

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29126 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5133

Showing number of triples: 1 to 46 of 46.